org placeholder image

Rajesh Mudnaik

Director Pharmaceutical Product Development at Guardian Drug Company

  • LinkedIn

Email Email: m****@allergan.com

phone noPhone Number: (***)-***-****

map
GUARDIAN DRUG COMPANY

GUARDIAN DRUG COMPANY

  • description Description
    Guardian Drug Company was founded in 1984 by Dr. Arvind Dhruv. Guardian is one of the nation's largest manufacturers of over-the-counter (OTC) pharmaceuticals. For 30 years, we have built a r...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 10 Million to 25 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Guardian Drug Company Org Chart and Mapping

Arvind Dhruv

Chief Executive Officer

Employees

Rajesh Mudnaik

Director Pharmaceutical Product Development

Dilip Pathak

Supervisor Production Pharmaceutical

Jyoti Tagde

Quality Control Chemist

My Velicheti

Product Development Scientist

Frequently Asked Questions Regarding Rajesh Mudnaik

Answer: Rajesh Mudnaik works for Guardian Drug Company as Director Pharmaceutical Product Development

Answer: Rajesh Mudnaik’s role in Guardian Drug Company is Director Pharmaceutical Product Development

Answer: Rajesh Mudnaik's email address is m***@gmail.com

Answer: Rajesh Mudnaik's business email address is m****@allergan.com

Answer: Rajesh Mudnaik’s direct phone number is (***)-***-****

Answer: Rajesh Mudnaik works in the industry of: Pharmaceuticals

Answer: Rajesh Mudnaik works Guardian Drug Company located at 2 Charles Ct, Dayton, New Jersey, 08810, United States

Answer: Guardian Drug Company's Director Pharmaceutical Product Development is Rajesh Mudnaik

Answer: Rajesh Mudnaik contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@allergan.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access